In recent days, AbCellera and Bruker resolved their global patent dispute, with Bruker agreeing to pay US$36 million upfront plus ongoing royalties on Beacon Optofluidic platform sales. At the same ...

Investors may be wondering whether Bruker is quietly turning into a value opportunity, or if the recent noise is just a distraction from deeper issues in the business. The stock has bounced 6.8% over ...

Shares of scientific instrument company Bruker (NASDAQ:BRKR). jumped 4.7% in the morning session after a company it ...

This unique gamma-ray source will generate a beam of gamma rays like those that existed in the first minutes of our universe after the Big Bang. The high-flux, monochromatic and energy-tunable gamma ...

RI Research Instruments, a company that is majority-owned by Bruker Corporation (Nasdaq: BRKR), today announced orders for key components and enabling subsystems for the research gamma ray source of ...

Hedge funds last week sold more U.S. healthcare stocks than they bought for the first time in 14 weeks, Goldman Sachs said in ...

Bruker faced a tough 2024, with aggressive M&A, $600M preferred issuance, rising debt, and execution issues prompting a ...

Detailed price information for Abcellera Biologics Inc (ABCL-Q) from The Globe and Mail including charting and trades.

Investing.com -- AbCellera Biologics Inc (NASDAQ:ABCL) stock surged 5.1% on Thursday after the company announced a global settlement with Bruker Corporation (NASDAQ:BRKR) that resolves their ongoing ...

AbCellera has reached a settlement and patent-license agreement to resolve patent litigation with Bruker Corporation. The biotechnology company said Thursday that it will receive a $36 million payment ...

Discover how AI, flow chemistry, and NMR come together in the PiPAC project to revolutionize scalable and autonomous API ...

According to The Fly, on December 9, 2025, Goldman Sachs started Bruker Corporation (NASDAQ:BRKR) with a Sell rating and a ...